|
|
|
Insider
Information: |
Higgins John L |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,806,928 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$49,374,432 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
2,806,928 |
|
|
Total
Value |
$49,374,432 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
11
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
6
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-34.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2012-06-29 |
4 |
A |
$10.12 |
$12,654 |
D/D |
1,250 |
109,525 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2007-06-15 |
4 |
B |
$6.70 |
$13,400 |
D/D |
2,000 |
152,000 |
2.81 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-12-31 |
4 |
A |
$84.53 |
$18,851 |
D/D |
223 |
235,310 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2021-06-30 |
4 |
A |
$85.91 |
$21,220 |
D/D |
247 |
338,095 |
0 |
- |
|
OABI |
OmniAb, Inc |
Director |
|
2023-05-23 |
4 |
OE |
$3.68 |
$33,120 |
D/D |
9,000 |
2,471,686 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2012-12-05 |
4 |
B |
$18.03 |
$36,060 |
D/D |
2,000 |
112,025 |
2.81 |
- |
|
OABI |
OmniAb, Inc |
Director |
|
2023-05-23 |
4 |
S |
$4.05 |
$36,450 |
D/D |
(9,000) |
2,462,686 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2018-08-16 |
4 |
OE |
$14.47 |
$43,511 |
D/D |
3,007 |
110,426 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2014-08-15 |
4 |
B |
$54.97 |
$54,970 |
D/D |
1,000 |
120,099 |
2.81 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-09-16 |
4/A |
S |
$88.06 |
$88,060 |
D/D |
(1,000) |
366,180 |
0 |
- |
|
TECH |
Techne Corp |
Director |
|
2024-05-14 |
4 |
OE |
$22.95 |
$91,800 |
D/D |
4,000 |
40,608 |
0 |
- |
|
OABI |
OmniAb, Inc |
Director |
|
2022-12-28 |
4 |
A |
$3.66 |
$94,845 |
D/D |
25,914 |
2,397,255 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-06-21 |
4 |
OE |
$21.00 |
$97,986 |
D/D |
4,666 |
143,837 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-09-05 |
4 |
OE |
$21.00 |
$105,000 |
D/D |
5,000 |
144,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2013-08-19 |
4 |
OE |
$16.14 |
$105,814 |
D/D |
6,556 |
116,581 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2019-05-31 |
4 |
B |
$108.20 |
$108,202 |
D/D |
1,000 |
144,899 |
2.81 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-08-08 |
4 |
OE |
$21.00 |
$115,143 |
D/D |
5,483 |
144,654 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2016-03-08 |
4 |
OE |
$21.00 |
$126,000 |
D/D |
6,000 |
125,664 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2022-11-18 |
4 |
OE |
$12.78 |
$127,800 |
D/D |
10,000 |
426,731 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-12-08 |
4 |
D |
$87.52 |
$147,296 |
D/D |
(1,683) |
235,087 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2020-12-08 |
4 |
OE |
$10.05 |
$147,303 |
D/D |
14,657 |
236,770 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-03-08 |
4 |
D |
$106.92 |
$157,493 |
D/D |
(1,473) |
143,171 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
|
2017-03-08 |
4 |
OE |
$10.05 |
$157,534 |
D/D |
15,675 |
144,644 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2014-02-12 |
4 |
OE |
$9.96 |
$168,075 |
D/D |
16,875 |
127,974 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
President & CEO |
|
2013-10-22 |
4 |
OE |
$10.05 |
$169,763 |
D/D |
10,518 |
117,099 |
0 |
- |
|
165 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|